Literature DB >> 14680729

Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting.

Robert J Scheubel1, Holger Zorn, Rolf-Edgar Silber, Oliver Kuss, Henning Morawietz, Juergen Holtz, Andreas Simm.   

Abstract

OBJECTIVES: The effect of patient age on circulating endothelial progenitor cells (EPCs) and their mobilization during coronary artery bypass grafting (CABG) was assessed.
BACKGROUND: The EPCs are able to contribute to reparative neovascularization after tissue ischemia. In experimental models, reparative neovascularization is impaired in senescent animals, but the role of EPCs in this impairment, especially in humans, is unknown.
METHODS: In 50 consecutive patients (43 to 80 years old) with stable coronary artery disease undergoing CABG, the numbers of EPCs and the plasma levels of interleukin (IL)-6, IL-8, IL-10, and IL-18, as well as vascular endothelial growth factor (VEGF) and placental growth factor, were determined preoperatively, after coming off bypass, and 6, 12, 24, and 72 h postoperatively.
RESULTS: Preoperative values of EPCs were lowered with increasing age, similar to the lowering of plasma VEGF levels. These age-associated decreases could not be explained by differences in atherosclerotic risk factors or cardiac function. Bypass surgery induced a rapid mobilization in EPCs, IL-6, IL-8, IL-10, and VEGF, with a peak 6 h postoperatively. Persistently lower levels of EPCs and VEGF throughout the observation period were observed in patients >69 years old, which could not be explained by differences in the operative procedure or inflammatory IL activation.
CONCLUSIONS: Despite a significant increase in EPCs and release of cytochemokines during CABG, age is a major limiting factor for mobilization of EPCs. Further studies are necessary to improve the strategies for mobilization, ex vivo expansion, and re-transplantation of EPCs in aging patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680729     DOI: 10.1016/j.jacc.2003.07.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  105 in total

1.  Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial.

Authors:  Çağdaş Baran; Serkan Durdu; Klara Dalva; Çagın Zaim; Arın Dogan; Gokhan Ocakoglu; Günhan Gürman; Önder Arslan; Ahmet Rüçhan Akar
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  Percutaneous coronary intervention in the elderly.

Authors:  Tracy Y Wang; Antonio Gutierrez; Eric D Peterson
Journal:  Nat Rev Cardiol       Date:  2010-12-07       Impact factor: 32.419

3.  Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome.

Authors:  Shmuel Schwartzenberg; Arnon Afek; Gideon Charach; Ardon Rubinstein; Yossi Ben-Shoshan; Sarina Kissil; Sofia Maisel-Auslender; Gad Keren; Jacob George
Journal:  World J Cardiol       Date:  2010-09-26

4.  Platelet reduction after stentless pericardial aortic valve replacement.

Authors:  Alberto Repossini; Daniel Bloch; Claudio Muneretto; Paolo Piccoli; Gianluigi Bisleri; Sven Beholz
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-24

5.  Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes.

Authors:  Hwi Gon Kim; Ook Hwan Choi
Journal:  Heart Vessels       Date:  2010-12-25       Impact factor: 2.037

6.  Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction.

Authors:  Gennaro Galasso; Stephan Schiekofer; Kaori Sato; Rei Shibata; Diane E Handy; Noriyuki Ouchi; Jane A Leopold; Joseph Loscalzo; Kenneth Walsh
Journal:  Circ Res       Date:  2005-12-22       Impact factor: 17.367

7.  Genetic and clinical correlates of early-outgrowth colony-forming units.

Authors:  Stanley Y Shaw; Susan Cheng; L Adrienne Cupples; Martin G Larson; Elizabeth L McCabe; Julius S Ngwa; Ying A Wang; Roderick P Martin; Rachael J Klein; Basma Hashmi; Olujimi A Ajijola; Evan Lau; Christopher J O'Donnell; Ramachandran S Vasan; Kenneth S Cohen; Thomas J Wang
Journal:  Circ Cardiovasc Genet       Date:  2011-04-14

8.  Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.

Authors:  Wen-Ching Shen; Chan-Jung Liang; Vin-Cent Wu; Shu-Huei Wang; Guang-Huar Young; I-Rue Lai; Chung-Liang Chien; Seu-Mei Wang; Kwan-Dun Wu; Yuh-Lien Chen
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

9.  Cord blood endothelial progenitor cells as therapeutic and imaging probes.

Authors:  Branislava Janic; Ali S Arbab
Journal:  Imaging Med       Date:  2012-08-01

Review 10.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

Authors:  Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.